Delcath Systems, Inc. financial data

Symbol
DCTH on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
566 Queensbury Avenue, Queensbury, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 314 % +31.1%
Quick Ratio 44.1 % +124%
Debt-to-equity 85.5 % -74.8%
Return On Equity -110 % +84.4%
Return On Assets -59.2 % +57.2%
Operating Margin -33.4 % +98.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33.4M shares +36%
Common Stock, Shares, Outstanding 33.1M shares +45.2%
Entity Public Float 206M USD +152%
Common Stock, Value, Issued 331K USD +45.2%
Weighted Average Number of Shares Outstanding, Basic 28.5M shares +75.7%
Weighted Average Number of Shares Outstanding, Diluted 28.5M shares +75.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 7.77M USD +1469%
Revenue from Contract with Customer, Excluding Assessed Tax 37.2M USD +1702%
Cost of Revenue 6.19M USD +874%
Research and Development Expense 13.9M USD -20.7%
Operating Income (Loss) -12.4M USD +67.5%
Net Income (Loss) Attributable to Parent -26.4M USD +44.7%
Earnings Per Share, Basic -0.93 USD/shares +68.4%
Earnings Per Share, Diluted -0.93 USD/shares +68.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.4M USD +156%
Accounts Receivable, after Allowance for Credit Loss, Current 10.9M USD +4419%
Inventory, Net 6.93M USD +109%
Assets, Current 73.8M USD +98.5%
Property, Plant and Equipment, Net 1.79M USD +32.4%
Operating Lease, Right-of-Use Asset 1.04M USD +909%
Assets 76.6M USD +98.4%
Accounts Payable, Current 961K USD -5.04%
Employee-related Liabilities, Current 3.47M USD +86.7%
Accrued Liabilities, Current 5.08M USD -3.26%
Liabilities, Current 6.14M USD -62.6%
Operating Lease, Liability, Noncurrent 933K USD
Other Liabilities, Noncurrent 766K USD -8.81%
Liabilities 7.84M USD -65.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 82K USD -39.3%
Retained Earnings (Accumulated Deficit) -532M USD -5.22%
Stockholders' Equity Attributable to Parent 68.7M USD +336%
Liabilities and Equity 76.6M USD +98.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.58M USD -125%
Net Cash Provided by (Used in) Financing Activities 4.02M USD -75.9%
Net Cash Provided by (Used in) Investing Activities 4.66M USD
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 33.1M shares +45.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -886K USD -107%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.3M USD -79.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 250K USD -49.1%
Deferred Tax Assets, Valuation Allowance 42.1M USD +7.05%
Deferred Tax Assets, Gross 42.3M USD +7.65%
Operating Lease, Liability 1.04M USD +908%
Depreciation 134K USD +4.69%
Payments to Acquire Property, Plant, and Equipment 13K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -26.4M USD +44.3%
Lessee, Operating Lease, Liability, to be Paid 1.45M USD +1175%
Property, Plant and Equipment, Gross 6.74M USD +4.93%
Operating Lease, Liability, Current 105K USD +184%
Lessee, Operating Lease, Liability, to be Paid, Year Two 168K USD +282%
Lessee, Operating Lease, Liability, to be Paid, Year One 185K USD +320%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 415K USD +3673%
Lessee, Operating Lease, Liability, to be Paid, Year Three 148K USD +469%
Deferred Tax Assets, Operating Loss Carryforwards 29.1M USD -2.69%
Preferred Stock, Shares Issued 14.2K shares -42.8%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 152K USD
Operating Lease, Payments 13K USD -87.7%
Additional Paid in Capital 600M USD +15.2%
Preferred Stock, Shares Outstanding 14.2K shares -42.8%
Share-based Payment Arrangement, Expense 9.77M USD +19.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%